ConductScience.org, home

Paper29891789

Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Zayed MF and 5 others. Int J Mol Sci, 2018. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. Papers, record 29891789. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29891789

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.11
iCite
Revised in PubMed
2019-08-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zayed MFMohamed F
2Ahmed SSahar
3Ihmaid SSaleh
4Ahmed HEAHany E A
5Rateb HSHeba S
6Ibrahim SRMSabrin R M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
ErbB ReceptorsMajor topic
Molecular Docking SimulationMajor topic
PolymerizationMajor topic
QuinazolinonesMajor topic
TubulinMajor topic
Binding Sites
Cell Death
Cell Line, Tumor
Colchicine
Erlotinib Hydrochloride
Humans
Inhibitory Concentration 50

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125174978Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives.Cent Nerv Syst Agents Med Chem2014https://conductscience.org/library/papers/25174978PubMed
210592235The Protein Data Bank.Nucleic Acids Res2000https://conductscience.org/library/papers/10592235PubMed
318950904Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.Eur J Med Chem2009https://conductscience.org/library/papers/18950904PubMed
429227917Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents.Bioorg Chem2018https://conductscience.org/library/papers/29227917PubMed
519664865
Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I.
Eur J Med Chem2009https://conductscience.org/library/papers/19664865PubMed
616971132Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.Bioorg Med Chem2006https://conductscience.org/library/papers/16971132PubMed
724648828Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents.Saudi Pharm J2014https://conductscience.org/library/papers/24648828PubMed
816366606New potential anticancer agents based on the anthranilic acid scaffold: synthesis and evaluation of biological activity.J Med Chem2005https://conductscience.org/library/papers/16366606PubMed
923487401Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents.Drug Res (Stuttg)2013https://conductscience.org/library/papers/23487401PubMed
1015072839Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones.Eur J Med Chem2004https://conductscience.org/library/papers/15072839PubMed
1129317147Fusarithioamide B, a new benzamide derivative from the endophytic fungus Fusarium chlamydosporium with potent cytotoxic and antimicrobial activities.Bioorg Med Chem2018https://conductscience.org/library/papers/29317147PubMed
1228215601Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.Bioorg Chem2017https://conductscience.org/library/papers/28215601PubMed
1329385728The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization.Int J Mol Sci2018https://conductscience.org/library/papers/29385728PubMed
1412735990Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones.Bioorg Med Chem2003https://conductscience.org/library/papers/12735990PubMed
1522551678New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.Eur J Med Chem2012https://conductscience.org/library/papers/22551678PubMed
1620724039Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.Eur J Med Chem2010https://conductscience.org/library/papers/20724039PubMed
1720510483Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1.Eur J Med Chem2010https://conductscience.org/library/papers/20510483PubMed
1829280968
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Molecules2017https://conductscience.org/library/papers/29280968PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42136942Discovery of novel quinazoline-sulfonamide derivatives with promising antidiabetic activity.Front Chem2026https://conductscience.org/library/papers/42136942PubMed
41599658Design, Synthesis, and Biological Evaluation of N-Acyl-Hydrazone-Linked Quinazolinone Derivatives with Antioxidant, Antimicrobial, and Anticancer Potential.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599658PubMed
41379296Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.Mol Divers2026https://conductscience.org/library/papers/41379296PubMed
41053651Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases.BMC Cancer2025https://conductscience.org/library/papers/41053651PubMed
40106127Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy.Mol Divers2025https://conductscience.org/library/papers/40106127PubMed
389656306-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.BMC Chem2024https://conductscience.org/library/papers/38965630PubMed
38899242Quinazoline Derivatives as Targeted Chemotherapeutic Agents.Cureus2024https://conductscience.org/library/papers/38899242PubMed
37569792Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs.Int J Mol Sci2023https://conductscience.org/library/papers/37569792PubMed
35631362A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs).Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35631362PubMed
34832895New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34832895PubMed
30746734Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.Med Res Rev2019https://conductscience.org/library/papers/30746734PubMed
30002297Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.Molecules2018https://conductscience.org/library/papers/30002297PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29891789

GET https://conductscience.org/api/papers/v1/29891789/authors